THE EFFECT OF SELEGILINE AND BROMOCRIPTINE IN THE PROPHYLAXIS OF PERPHENAZINE-INDUCED PSEUDOPARKINSONISM IN RAT: A COMPARATIVE STUDY

AuthorA Arzien
AuthorA.A Hemmatien
AuthorM.H Pipelzadehen
AuthorS.M Latifien
AuthorF Rameshen
Issued Date2006-12-20en
AbstractParkinsonism is a neurodegenerative disease that is defiend by certain symtom as muscle rigidity , impaired movement , tremor and disorientation of body. The aim of the present study was to compare the efficacy of selegiline and bromocriptine in the prevention of experimentally induced pseudoparkinsonism in rat. Perphenazine (5mg/kg) was used (IP) as the inducing agent. Different groups of rats were pretreated by either selegiline (2.5, 5, 10, and 20mg/kg), or effective dose of bromocriptine (30mg/kg). The degree of prevention of catatonic reaction was compared with control group. The results showed all selegiline-treated groups had significant reduction in the catatonic reaction relative to sham treated group. In addition, 20mg/kg selegiline had more intensive effect to reduce the catatonic reaction than bromocriptine (30mg/kg). Selegiline seems to be a suitable drug to prevent perphenazine–induced catatonia in rat.en
DOIhttps://doi.org/en
KeywordPseudoparkinsonismen
KeywordSelegilineen
KeywordBromocriptineen
KeywordCatatonic reactionen
KeywordRaten
PublisherBrieflandsen
TitleTHE EFFECT OF SELEGILINE AND BROMOCRIPTINE IN THE PROPHYLAXIS OF PERPHENAZINE-INDUCED PSEUDOPARKINSONISM IN RAT: A COMPARATIVE STUDYen
TypeResearch Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
72418-pdf.pdf
Size:
61.02 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF